Literature DB >> 1651569

Soluble thrombomodulin antigen in conditioned medium is increased by damage of endothelial cells.

H Ishii1, H Uchiyama, M Kazama.   

Abstract

Thrombomodulin (TM) exists not only in endothelial cells but also in circulating plasma as soluble heterogeneous fragments. A release mechanism of soluble TM antigen from endothelial cells was investigated. Cultured human umbilical vein endothelial cells released about 0.6% of total cellular TM antigen into conditioned medium during 24 h. The release of TM antigen was not influenced by addition of various concentrations (0.01-5.0 microM) of monensin, which inhibits intracellular transport of secretory proteins, though the secretion of plasminogen activator inhibitor-1 from the cells was inhibited. The release of TM antigen was not increased when total cellular TM level increased 1.3- or 1.4-fold relative to control cells after stimulation with 0.1-1.0 U/ml thrombin or 3 mM dibutyryl cAMP, respectively. Exposure of endothelial cells for 6 h to mixture of 1 microM N-formyl-methionyl-leucyl-phenylalanine (FMLP) and 100 ng/ml lipopolysaccharide (LPS) decreased cellular TM level by 30% relative to control cells without increase in the TM release. The FMLP and LPS-stimulated leukocyte treatment of the cells increased the release of TM antigens into the medium in a time-dependent manner and the increased release of TM antigen paralleled the extent of cell damage as measured by 51Cr release. Hydrogen peroxide treatment of the cells increased the release of TM antigens into the medium in a time- and concentration-dependent manner. The increased release of TM antigen by hydrogen peroxide also paralleled the extent of cell damage.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1651569

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  39 in total

1.  Soluble thrombomodulin concentration is raised in scleroderma associated pulmonary hypertension.

Authors:  R J Stratton; L Pompon; J G Coghlan; J D Pearson; C M Black
Journal:  Ann Rheum Dis       Date:  2000-02       Impact factor: 19.103

2.  Functional heterogeneity of anti-endothelial cell antibodies.

Authors:  A Bordron; R Révélen; F D'Arbonneau; M Dueymes; Y Renaudineau; C Jamin; P Youinou
Journal:  Clin Exp Immunol       Date:  2001-06       Impact factor: 4.330

Review 3.  Coagulation in sepsis.

Authors:  André Amaral; Steven M Opal; Jean-Louis Vincent
Journal:  Intensive Care Med       Date:  2004-05-18       Impact factor: 17.440

4.  Serological tests for diagnosis and staging of hand-arm vibration syndrome (HAVS).

Authors:  Dennis S Kao; Ji-Geng Yan; Lin-Ling Zhang; Rachel E Kaplan; Danny A Riley; Hani S Matloub
Journal:  Hand (N Y)       Date:  2007-10-03

5.  Angiogenic Factors Correlate with T Cell Immune Reconstitution and Clinical Outcomes after Double-Unit Umbilical Cord Blood Transplantation in Adults.

Authors:  Ioannis Politikos; Haesook T Kim; Theodoros Karantanos; Julia Brown; Sean McDonough; Lequn Li; Corey Cutler; Joseph H Antin; Karen K Ballen; Jerome Ritz; Vassiliki A Boussiotis
Journal:  Biol Blood Marrow Transplant       Date:  2016-10-21       Impact factor: 5.742

6.  Persistence of endothelial thrombomodulin in a patient with infectious purpura fulminans treated with protein C concentrate.

Authors:  Pavan K Bendapudi; Alissa Robbins; Nicole LeBoeuf; Olga Pozdnyakova; Ami Bhatt; Fujiko Duke; Ryan Sells; John McQuiston; Ben Humrighouse; Betty Rouaisnel; Meaghan Colling; Kathryn E Stephenson; Arturo Saavedra; Julie-Aurore Losman
Journal:  Blood Adv       Date:  2018-11-13

7.  Elevation of the soluble thrombomodulin levels is associated with inflammation after percutaneous coronary interventions.

Authors:  Ting-Hsing Chao; Yi-Heng Li; Wei-Chuan Tsai; Jyh-Hong Chen; Ping-Yen Liu; Liang-Min Tsai
Journal:  Clin Cardiol       Date:  2004-07       Impact factor: 2.882

8.  Vascular origin of Kaposi's sarcoma. Expression of leukocyte adhesion molecule-1, thrombomodulin, and tissue factor.

Authors:  Y M Zhang; S Bachmann; C Hemmer; J van Lunzen; A von Stemm; P Kern; M Dietrich; R Ziegler; R Waldherr; P P Nawroth
Journal:  Am J Pathol       Date:  1994-01       Impact factor: 4.307

9.  Cytokine regulation of hemostatic property and IL-6 production of human endothelial cells.

Authors:  Y Hashimoto; S Hirohata; T Kashiwado; K Itoh; H Ishii
Journal:  Inflammation       Date:  1992-12       Impact factor: 4.092

10.  Successful treatment of rheumatoid arthritis is associated with a reduction in serum sE-selectin and thrombomodulin level.

Authors:  Veli Cobankara; Düzgün Ozatli; Sedat Kiraz; Mehmet Akif Oztürk; Ihsan Ertenli; Tufan Türk; Sule Apras; Ibrahim C Haznedaroglu; Meral Calgüneri
Journal:  Clin Rheumatol       Date:  2004-06-19       Impact factor: 2.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.